GlassScriptPhysician profile
Mansoor Ahmad
NPI 1194059600
$3,490.34
in general payments reported to CMS, 2019-2025
17 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $74.97 · 2021: $742 · 2022: $1,216 · 2023: $458 · 2024: $487 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.67 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,031.22 | 2021-2023 | Coroflow, Optis |
| Janssen Pharmaceuticals, INC | $448.65 | 2019-2022 | |
| Boston Scientific Corporation | $358.40 | 2022-2025 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $346.76 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $260.85 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.68 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $146.23 | 2022-2025 | Wegovy |
| Medtronic, INC. | $132.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.38 | 2022-2025 | |
| Pfizer INC. | $92.37 | 2021-2023 | |
| Biosense Webster, INC. | $83.47 | 2023 | Na, Nuvision Ice Catheter, Soundstar |
| E.R. Squibb & Sons, L.L.C. | $76.00 | 2021 | |
| Getinge USA Sales, LLC | $47.07 | 2022-2023 | Cs300 Intra-Aortic Balloon Pump, English, 110v |
| Heartflow, INC. | $45.99 | 2025 | |
| Impulse Dynamics (USA) INC. | $45.94 | 2025 | Optimizer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $21.32 | 2023 | Inpefa |
| Abiomed | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansoor Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.